CBFB and leukemia: Collectively, these results corroborate our previous findings, facilitate a better molecular understanding of the role of CBFβ-MYH11 in the pathogenesis of leukemia, and might ultimately help to improve therapy decision of inv(16) AML by designing specific (epi)drugs to reprogram GATA2 or other target genes.